chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Running nose; Fatigue; Drip-age that causes sore throat (starting day 2-3 after vaccination and is current).; This is a spontaneous report from a contactable other healthcare professional (HCP) reporting for herself.  A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE on 15Jan2021 14:00 at single dose for covid-19 immunisation. Medical history included history of stroke and current depression, ongoing.  No allergy to medications, food, or other products. Concomitant medication included topiramate (TOPAMAX) and acetylsalicylic acid (ASPIRIN) and Celebs (as reported), all within 2 weeks of vaccination.  Patient was not pregnant and was not pregnant at the time of vaccination. On 15Jan2021 at 16:00 the patient experienced running nose and fatigue; she had "drip-age" that caused sore throat, starting day 2-3 after vaccination (Jan2021) and was current (as reported). No treatment given for the events. Fatigue last same day and 2 days after. Final outcome of running nose and fatigue was reported as unknown; outcome of the other event was not recovered. Information on the lot/batch number has been requested.
This is a spontaneous report from a contactable consumer, the patient's mother. An 11-month-old male patient received a dose of either PRENAR or PREVNAR 13, via an unspecified route of administration on 27Jul2012 at 3:30 pm at a single dose for vaccination. The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccine 4 weeks prior to receiving either PREVNAR or PREVNAR 13; but he was administered two unspecified vaccines 5 weeks ago in 2012. On 27Jul2012 at 4:30 pm, one hour after receiving the vaccine, the patient had a fever. On 30Jul2012, the patient developed cold symptoms. Therapeutic measures were taken as a result of the fever and cold symptoms and included treatment with MOTRIN and TYLENOL, both at 1.875 ml alternating every four hours. the patient had recovered from the fever on 29Jul2012 and had recovered from the cold symptoms on 03Aug2012.
This case was reported by a nurse and described the occurrence cellulitis in an 18 month old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. The pt had no relevant medical history and received no concurrent medications. This pt had no adverse experiences following previous immunizations.  On 04Nov2003, the pt received his fourth dose of Infanrix in the left thigh. Also on 04Nov2003, the pt received poliomyelitis virus vaccine inactivated (IPOL). At an unspecified time on 04Nov2003, the pt experienced cellulitis and an injection site reaction characterized by redness and swelling. The pt was seen in a physician's office and treated with an unspecified antibiotic. The events resolved after an unspecified period of time. The nurse considered the events to be possibly related to vaccination with Infanrix.
Had my first dose of Moderna on March 10th. My last period before the vaccine was February 25th. I did not have a period the entire month of March and did not get a period until April 25th. I am not on birth control and always have regular and on time periods. The vaccine caused me to have 1 missed period and 1 late period.
Hives; Itching; Area still has redness; warm to the touch; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives), PRURITUS (Itching), INJECTION SITE ERYTHEMA (Area still has redness) and INJECTION SITE WARMTH (warm to the touch) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Drug allergy (reacts to gelatin in capsules). Concurrent medical conditions included Drug allergy (reacting to the gylcerol from the vaccine). Concomitant products included METOPROLOL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), RAMIPRIL, METFORMIN, CALCIUM CITRATE, ERGOCALCIFEROL (CAL CITRATE PLUS VITAMIN D) and SITAGLIPTIN (JANUVIA [SITAGLIPTIN]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced URTICARIA (Hives), PRURITUS (Itching), INJECTION SITE ERYTHEMA (Area still has redness) and INJECTION SITE WARMTH (warm to the touch). At the time of the report, URTICARIA (Hives), PRURITUS (Itching), INJECTION SITE ERYTHEMA (Area still has redness) and INJECTION SITE WARMTH (warm to the touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Narrative:  COVID infection following COVID vaccine series 01/14, Pfizer, dose #1 02/04, Pfizer, dose #2 10/26, Pfizer, dose #3 09/28 pt cc: fatigue and sob exposure: unknown 09/30 COVID swab, result: not detected 10/01 CXR impression: No acute cardiopulmonary findings. 10/01 SARS-COV-2 Variant Sequencing result: pending 10/05 COVID swab, result: detected 10/06 pt admit to medicine cc: "persistent COVID symptoms" dx: COVID-19 PNA w/ Hypoxia LOS: 3 10/06 LACTIC ACID: 0.83 10/06 PT/INR 12.4/1.11 10/06 DDIMER: 2.69 10/06 PROCALCITONIN: 0.08 10/06 ESR: 33 10/06 i-pH 7.46, i-PCo2 37.9, i-PO2 64, i-HCO3 26.8 10/06 CTA PE impression: Bilateral Covid pneumonia. No pulmonary embolism. 10/06 CXR impression: No acute abnormality. No change since 5 years ago. 10/07 DDIMER: 2.55 10/08 DDIMER: 2.53 10/09 DDIMER: 2.41 10/11 CRP 0.662 10/11 FERRITIN: 175.7 10/11 FIBRINOGEN: 274 10/11 DDIMER: 2.72 10/11 CXR impression: Unremarkable cardiomediastinal silhouette. Calcification of the aortic arch. Right lower lung focal opacity could represent nipple shadow, summation artifact, or parenchymal lesion. Follow-up frontal radiograph with nipple markers suggested. No large focal consolidation, pleural effusions, and thorax. No acute osseous abnormalities seen. 10/17 clinically resolved
p/vax pt started getting flush & c/o SOB & chest tightness;code 4 called; pt given 2 shots of epi, 2NTG tablets sublingual, IV fluids; pressure low;c/o itching all over & nausea but no vomiting or abd pain;MI r/o and pt d/c p/ several hr;
A Pediatrician reported via a company representative that a patient received a first dose of Prevnar vaccine and subsequently developed induration at the injection site. No further information was available at the date of this report.
Swelling of throat, flushed. HR-80. No problems breathing no wheezing. EPIPEN given (.30 mg) (L) outer thigh at 1:03pm (patient had already taken BENADRYL and CLARITIN). EMS arrived. Recommended going to ED or doctor. Patient refused EMS ride.
Patient developed a 5 cm x 5 cm red, warm area on 9-12-08 on anterior upper right thigh.  Tx consisted of advising parent to do warm compresses Q.I.D. and to follow up if symptoms persist or worsen.
Upper arms felt cold. Complained of lower leg pain which subsided with walking. BP 146/65 (pulse 59). 100% O2 sat.
Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 28Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), outcome "not recovered", described as "Diarrhea".  Additional information: The patient received the first dose about a week ago and experienced diarrhea for a week now (at the time of report) after receiving the dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Systemic: Lymph Node Swelling-Mild, Additional Details: Patient started experiencing lymph node swelling (" knot" - as per patient)on left collar bone  05/07/21 . The patient still feels the 'knot" but is not limiting patient from performing daily activities. Recommended patient to contact primary physician to make a shared clinical decision on receiving second dose . Patient is also given contact info for moderna
soreness of the arm,; Huge swelling of the lymph node under her arm, too bad she can not put her arm down; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness of the arm,) and VACCINATION SITE LYMPHADENOPATHY (Huge swelling of the lymph node under her arm, too bad she can not put her arm down) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Allergy pill treatment).    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2020, the patient experienced VACCINATION SITE PAIN (soreness of the arm,) and VACCINATION SITE LYMPHADENOPATHY (Huge swelling of the lymph node under her arm, too bad she can not put her arm down). At the time of the report, VACCINATION SITE PAIN (soreness of the arm,) and VACCINATION SITE LYMPHADENOPATHY (Huge swelling of the lymph node under her arm, too bad she can not put her arm down) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       o No treatment medications provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Patient was admitted to observation status on on 2-5 for treatment of AKI related to IV contrast from head and neck angio CT on 2/1. It is noted that the patient tested positive for covid on 2-5-22.
Fever, headache,brain foggyness, chest pain at the sternum, nausea,
Patient describes shortness of breath since time of vaccination. She has SOB with walking. Saw own doctor on 6/3 who did EKG and other tests on 6/4 and has not heard from doctor about results.
Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Cardiac Disorder (diagnosed by MD)-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Severe, Systemic: Tachycardia-Severe
Information has been received from a physician concerning a 2 month old female who was vaccinated PO with a dose of Rotateq. Concomitant vaccinations administered at the time included a dose of diphtheria toxoid (+) pertussis accellular vaccine (unspecified) (+)tetanus toxoid and a dose of poliovirus vaccine inactivated (unspecified). The physician reported that, within 36 hours of being vaccinated, the patient developed vomiting. It was unknown if medical attention was sought and the patient was not hospitalized. At the time of this report, the outcome was unknown. Additional information has been requested.
Headache; fever Registered a 102F Temperature Taken on Neck; Body fatigue; arm/joint pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (fever Registered a 102F Temperature Taken on Neck), FATIGUE (Body fatigue), ARTHRALGIA (arm/joint pain) and CHILLS (chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HEADACHE (Headache), PYREXIA (fever Registered a 102F Temperature Taken on Neck), FATIGUE (Body fatigue), ARTHRALGIA (arm/joint pain) and CHILLS (chills). At the time of the report, HEADACHE (Headache), PYREXIA (fever Registered a 102F Temperature Taken on Neck), FATIGUE (Body fatigue), ARTHRALGIA (arm/joint pain) and CHILLS (chills) had not resolved. Possible    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature: 102 102F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Pt received MMR and VZV vaccines for catch-up vaccination.  (Had previously received MMRV #2 within 28 days of another live attenuated vaccine -- nasal influenza vaccine on 12/2/10 and MMRV on 12/28/10.)  Within 30 minutes of receiving vaccines, pt developed signs/symptoms of severe allergic reaction requiring dose of IM epinephrine x 1 in clinic.  Transferred to ED, received antihistamines and oral steroids but no further epinephrine.  Recovered fully, discharged within 4 hours, fully recovered by 24 hours, no further medical care sought at time of submission of this form
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 08/20/2021. PATIENT FULL VACCINATED ON 06/04/2021.
Within 5 minutes, it appeared tongue was swelling a bit.  A metallic taste was also present.  Next 3 days, mild fatigue, low grade fever, headache and sore arm were experience.  Day 4 light headedness and fatigue increased and grew progressively worse each day.  Heartbeat & blood pressure elevated over normal, but not in dangerous zone. It felt like when I had anemia years earlier. Day 8 I went to urgent care, suspecting anemia.  Blood test was normal, except for slightly lower sodium. Day 9 I followed up with regular doctor, and Thyroid test was ordered.  It was normal.  Day 10 tongue swelling and metallic taste improved, and other symptoms started to subside.  As of day 18, all symptoms gone, I felt "normal" again and was able to resume regular activity and exercise routine.
Patient received vaccine on Jan 22nd at 1:42 pm. Patient stated she woke up at 2:00 am with severe shortness of breath and felt as if she had a cement brick on her chest. She struggled to breath all night, and paced the house. Patient states she felt as if she was going to die. Patient did not wake anyone up or tell anyone, so vitals or other information could not be obtained during the reaction. Patient felt better Saturday morning, but still very fatigued and very fearful.
This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 10-year-old male patient who received DTPa (Infanrix) (batch number 23T73, expiry date 30th April 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 10th December 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 10th December 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse manager reported that, the patient received infanrix vaccine instead of Boostrix, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021071603:same reporter
Patient requested Moderna as her 2nd shot (1st was done out of the country), however, I injected her with Pfizer by mistake.  I only realized my mistake after the fact.  Patient seemed fine after the shot (10 min after administration).  I gave my name and I assured her that she does not need additional dose as per conversation with my district manager.
Headache, Sedation, Myalgia, Arthralgia, Angioedema, Rash,  Chills, fatigue, and tiredness  Narrative:
Immunocompromised patient received a Booster dose instead of a Third dose; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Immunocompromised patient received a Booster dose instead of a Third dose) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 071F21A, 010A21A and 037A21B) for COVID-19 vaccination.     The patient's past medical history included Immunosuppression in February 2022. Concurrent medical conditions included Cancer (NOS).   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 29-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced UNDERDOSE (Immunocompromised patient received a Booster dose instead of a Third dose). At the time of the report, UNDERDOSE (Immunocompromised patient received a Booster dose instead of a Third dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had no allergies and never tested positive for Covid-19.  She received Pneumonia and Shingles vaccine but HCP could not confirm the date of administration. No treatment medications were reported. Patient experienced no symptoms after the Booster dose.
Patient was administer Moderna Booster (80777-0275-99) in place of Moderna Bivalent Booster (80777-0282-99).
SEVERE PAIN at the injection site, beginning two weeks after the injection.   It's excruciating, so I've been lying on the couch for 7 days so far, with no end in sight.  It kills me to move my arm, so I only get up to use the bathroom.  I'm taking 1000 mgs of Tylenol and 200 mgs of Motrin every 8 hours with very little effect (if any).  I've called my doctor twice, but they said they can't do anything unless I go in, which is impossible because of the pain.  The nurse said they probably couldn't do anything, anyway,
Information has been received from a registered nurse concerning a male with no patient medical history who on approximately 07-JUL-2009 "one week ago" was vaccinated with ZOSTAVAX (Merck). On 13-JUL-2009 the patient developed agitation, dementia and delirium. The patient went to an emergency room and admitted into the hospitalized. The patient's agitation, dementia and delirium persisted. Dementia and delirium were considered to be disabling by the reporter. Additional information has been requested.
on 3/16 her husband said he woke her up and she was conscious but unresponsive, couldn't make sense of instruction, didnt know who her husband or herself was, went to er via ambulance 12 hours she "snapped back into reality"
Tachycardia, Chest pain, possible EKG changes in T waves. Started at 1:00Pm, 22 hours post vaccination. Resolved by 36 hours post-vaccination.
Patient presented to the ED on 3/8/2021 after being diagnosed with a UTI on 3/7/2021. Her reported feeling more weak and consistent fever. Reason for admission: UTI. Per EUA, all hospitalization must be reported after recently receiving a vaccine. This hospitalization does not seem related to the vaccine
Inflammation on left arm, itchiness and redness, painful arm unable to move left arm. Numbness and tingling on left hand fingers
Fatigue, muscle and joint pain, headache, swollen lip and gums. All symptoms severe for 48 hours, ongoing.
Shingles; ill defined disorder; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of an unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 05-FEB-2008, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dose, dose # and route not specified) for the long-term prevention of singles and zoster-related conditions. Subsequently on an unknown date, the patient was treated for singles and other zoster related injuries( ill-defined disorder). The outcome of herpes zoster and ill-defined disorder was unknown. The reporter considered herpes zoster and ill-defined disorder to be related to Zoster Vaccine Live(ZOSTAVAX).
Patient was given a dose (0.5mL) of Moderna out of a vial that had been opened >12hours.
Body aches; 100.2 temp; Nausea; Fatigue; Pain on injection site; This is a spontaneous report from a contactable healthcare professional, the patient. A 41-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8733) via an unspecified route of administration on her left arm on 28Mar2021 (at the age of vaccination 41-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient had no concomitant medication reported. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since having the vaccine. On 28Mar2021 at 18:30, the patient experienced fever of 100.2 temperature, body aches, nausea, fatigue and pain on injection site. The patient received treatment care at home since day 1. The adverse events did not result in hospital or doctor visit. The clinical outcome of the events fever, body aches, nausea, fatigue and pain on injection site was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
I had an unique reaction to the Johnson&Johnson vaccine. 7 hours after getting the shot, my whole body went into painful spasms. My arms, legs, and torso were all twisting out of control. I was afraid I was going to fall out of my power chair, so I tilted it to prevent that from happening. Transfers were extremely difficult. My husband had to help me on and off of the toilet. This went on for about 3-4 hours. After 2 hours, I took some Tylenol to take the edge off of the spasms.
This spontaneous report as received from a pharmacist via a company representative refers to a patient of unknown age (reported as under the age of 50 years old) and gender. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiration date, dose, route were not reported). No adverse experiences were reported. This is one of several reports from the same reporter. Additional information has been requested.
Right arm sub q injection site were varicella vaccine given; red and swollen approximately grapefruit size. Hard to touch. States slight pain. Iced it and gave Benadryl but continues to get worse. Pt did go to emergency room to have evaluated 12/11/2014 and was diagnosed with an allergic reaction.
This spontaneous report was received from a pharmacy intern, and refers to a patient of unknown age and gender. The patient's medical history, current conditions and concomitant medications were not reported. On 16-OCT-2017, the patient was vaccinated with an expired dose of ZOSTAVAX lot number M032139, expiration date 02-OCT-2017, for prophylaxis (route of administration was not provided); reconstituted with sterile diluent (MERCK) lot number M016885, expiration date 07-DEC-2018. The reporter denied any adverse effects with the patient.